|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
5,366,000 |
Market
Cap: |
7.83(M) |
Last
Volume: |
140,704 |
Avg
Vol: |
0 |
52
Week Range: |
$0.506 - $1.83 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile SELLAS Life Sciences Group is a late-stage clinical biopharmaceutical company focused on developing cancer immunotherapeutics for a range of cancer indications. Co.'s product candidates include galinpepimut-S (GPS) and nelipepimut-S (NPS). Co.'s primary product candidate, GPS, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that targets the Wilms tumor 1 protein, which is present in 20 or more cancer types. NPS is a cancer immunotherapy targeting the human epidermal growth factor receptor 2 expressing cancers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
9,806 |
Total Sell Value |
$0 |
$0 |
$0 |
$25,516 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nisi Rudolph |
Director |
|
2017-10-10 |
4 |
A |
$0.38 |
$6,509 |
D/D |
17,130 |
42,918 |
|
- |
|
Galliker Stephens S |
Director |
|
2017-10-10 |
4 |
A |
$0.38 |
$5,249 |
D/D |
13,814 |
36,039 |
|
- |
|
Ashton William |
Director |
|
2017-10-10 |
4 |
A |
$0.38 |
$5,879 |
D/D |
15,472 |
38,154 |
|
- |
|
Ashton William |
Director |
|
2017-07-06 |
4 |
A |
$0.59 |
$5,821 |
D/D |
9,866 |
22,682 |
|
- |
|
Einhorn Irving M. |
Director |
|
2017-07-06 |
4 |
A |
$0.59 |
$5,405 |
D/D |
9,161 |
20,114 |
|
- |
|
Galliker Stephens S |
Director |
|
2017-07-06 |
4 |
A |
$0.59 |
$5,197 |
D/D |
8,809 |
22,225 |
|
- |
|
Hillsberg Sanford |
Director |
|
2017-07-06 |
4 |
A |
$0.59 |
$7,900 |
D/D |
13,390 |
35,953 |
|
- |
|
Chin Richard |
Director |
|
2017-07-06 |
4 |
A |
$0.59 |
$4,781 |
D/D |
8,104 |
18,631 |
|
- |
|
Gray Mary Ann |
Director |
|
2017-07-06 |
4 |
A |
$0.59 |
$5,821 |
D/D |
9,866 |
23,695 |
|
- |
|
Nisi Rudolph |
Director |
|
2017-07-06 |
4 |
A |
$0.59 |
$6,445 |
D/D |
10,924 |
25,788 |
|
- |
|
Nisi Rudolph |
Director |
|
2017-06-20 |
4 |
S |
$0.55 |
$273 |
D/D |
(500) |
14,864 |
|
- |
|
Nisi Rudolph |
Director |
|
2017-04-10 |
4 |
A |
$0.59 |
$6,447 |
D/D |
10,927 |
15,364 |
|
- |
|
Hillsberg Sanford |
Director |
|
2017-04-10 |
4 |
A |
$0.59 |
$7,902 |
D/D |
13,394 |
22,563 |
|
- |
|
Gray Mary Ann |
Director |
|
2017-04-10 |
4 |
A |
$0.59 |
$5,201 |
D/D |
8,815 |
13,829 |
|
- |
|
Galliker Stephens S |
Director |
|
2017-04-10 |
4 |
A |
$0.59 |
$5,820 |
D/D |
9,865 |
13,416 |
|
- |
|
Einhorn Irving M. |
Director |
|
2017-04-10 |
4 |
A |
$0.59 |
$5,096 |
D/D |
8,638 |
10,953 |
|
- |
|
Chin Richard |
Director |
|
2017-04-10 |
4 |
A |
$0.59 |
$4,783 |
D/D |
8,107 |
10,527 |
|
- |
|
Ashton William |
Director |
|
2017-04-10 |
4 |
A |
$0.59 |
$5,823 |
D/D |
9,870 |
12,816 |
|
- |
|
Gerber Sander |
10% Owner |
|
2017-02-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,400,000 |
|
- |
|
Gerber Sander |
10% Owner |
|
2017-02-08 |
4 |
S |
$0.84 |
$1,985,290 |
I/I |
(2,363,441) |
2,036,559 |
|
- |
|
Einhorn Irving M. |
Director |
|
2017-01-20 |
4 |
A |
$1.98 |
$5,000 |
D/D |
2,525 |
2,525 |
|
- |
|
Gray Mary Ann |
Director |
|
2017-01-20 |
4 |
A |
$1.98 |
$5,000 |
D/D |
2,525 |
5,004 |
|
- |
|
Ashton William |
Director |
|
2017-01-20 |
4 |
A |
$1.98 |
$5,833 |
D/D |
2,946 |
2,946 |
|
- |
|
Hillsberg Sanford |
Director |
|
2017-01-20 |
4 |
A |
$1.98 |
$7,916 |
D/D |
3,998 |
9,169 |
|
- |
|
Chin Richard |
Director |
|
2017-01-20 |
4 |
A |
$1.98 |
$4,792 |
D/D |
2,420 |
2,420 |
|
- |
|
90 Records found
|
|
Page 3 of 4 |
|
|